1 |
KOMOLOV K E, SULON S M, BHARDWAJ A,et al. Structure of a GRK5-calmodulin complex reveals molecular mechanism of GRK activation and substrate targeting[J]. Mol Cell, 2021, 81(2): 323-339.
|
2 |
GUO J J, YANG X H, WESTON D J, et al. Abscisic acid receptors: past, present and future[J]. J Integr Plant Biol, 2011, 53(6): 469-479.
|
3 |
BABA M, NAKAJO S, TU P H, et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies[J]. Am J Pathol, 1998, 152(4): 879-884.
|
4 |
ARAWAKA S, WADA M, GOTO S, et al. The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson’s disease[J].J Neurosci,2006,26(36): 9227-9238.
|
5 |
NIU B, LIU P P, SHEN M J, et al. GRK5 regulates social behavior via suppression of mTORC1 signaling in medial prefrontal cortex[J]. Cereb Cortex,2018,28(2): 421-432.
|
6 |
WANG S C, CHUNG R H, KUO H W, et al. GRK5 is associated with the regulation of methadone dosage in heroin dependence[J]. Int J Neuropsychopharmacol, 2018, 21(10): 910-917.
|
7 |
FRANKLIN J M, CARRASCO G A. G-protein receptor kinase 5 regulates the cannabinoid receptor 2-induced up-regulation of serotonin 2A receptors[J]. J Biol Chem, 2013, 288(22): 15712-15724.
|
8 |
BYCHKOV E R, GUREVICH V V, JOYCE J N,et al. Arrestins and two receptor kinases are upregulated in Parkinson’s disease with dementia[J]. Neurobiol Aging, 2008, 29(3): 379-396.
|
9 |
BARTHET G, CARRAT G, CASSIER E, et al. Beta-arrestin1 phosphorylation by GRK5 regulates G protein-independent 5-HT4 receptor signalling[J]. EMBO J, 2009, 28(18): 2706-2718.
|
10 |
FERNÁNDEZ-RUIZ I. GRK5 linked to cardiac dysfunction and leukocyte recruitment after MI[J]. Nat Rev Cardiol, 2021, 18(5): 308.
|
11 |
LIU L Y, LV J, LIN Z Q, et al. Co-overexpression of GRK5/ACTC1 correlates with the clinical parameters and poor prognosis of epithelial ovarian cancer[J]. Front Mol Biosci, 2021, 8: 785922.
|
12 |
JIANG L P, FAN S Q, XIONG Q X, et al. GRK5 functions as an oncogenic factor in non-small-cell lung cancer[J]. Cell Death Dis, 2018, 9(3): 295.
|
13 |
YE J, WEN Y, SUN X F, et al. Socioeconomic deprivation index is associated with psychiatric disorders: an observational and genome-wide gene-by-environment interaction analysis in the UK biobank cohort[J]. Biol Psychiatry, 2021, 89(9): 888-895.
|
14 |
COLIN M, DUJARDIN S, SCHRAEN-MASCHKE S, et al. From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy[J]. Acta Neuropathol, 2020, 139(1): 3-25.
|
15 |
MORIGUCHI S, TAKAHATA K, SHIMADA H,et al.Excess tau PET ligand retention in elderly patients with major depressive disorder[J].Mol Psychiatry,2021,26(10): 5856-5863.
|
16 |
TAKEUCHI H, IBA M, INOUE H, et al. P301S mutant human tau transgenic mice manifest early symptoms of human tauopathies with dementia and altered sensorimotor gating[J]. PLoS One, 2011,6(6): e21050.
|
17 |
SUN Y, GUO Y Q, FENG X J, et al. The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer’s disease[J]. J Neuroinflammation, 2020, 17(1): 72.
|
18 |
YOSHIYAMA Y, HIGUCHI M, ZHANG B, et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model[J]. Neuron, 2007, 53(3): 337-351.
|
19 |
奚耕思, 张武会. 抑郁症发生机制研究进展[J]. 陕西师范大学学报(自然科学版), 2011, 39(6): 64-71.
|
20 |
王 睿, 黄树明. 抑郁症发病机制研究进展[J]. 医学研究生学报, 2014, 27(12): 1332-1336.
|
21 |
MALHI G S, MANN J J. Depression[J]. Lancet, 2018, 392(10161): 2299-2312.
|
22 |
刘 聪, 韩金红, 王长虹. 海马神经元突触可塑性在抑郁症发病机制中的研究[J]. 中华行为医学与脑科学杂志, 2015, 24(5): 423-426.
|
25 |
FALDINI E, AHMED T, BUEÉ L, et al. Tau- but not Aß-pathology enhances NMDAR-dependent depotentiation in AD-mouse models[J]. Acta Neuropathol Commun, 2019, 7(1): 202.
|
24 |
MARZANO F, RAPACCIUOLO A, FERRARA N, et al. Targeting GRK5 for treating chronic degenerative diseases[J]. Int J Mol Sci, 2021, 22(4): 1920.
|
25 |
HULLMANN J E, GRISANTI L A, MAKAREWICH C A, et al. GRK5-mediated exacerbation of pathological cardiac hypertrophy involves facilitation of nuclear NFAT activity[J]. Circ Res, 2014, 115(12): 976-985.
|